Solid
Dispersions-An Approach to Enhance the Dissolution Rate of Clopidogrel
Bisulphate
Keerthi
Manukonda*, Rama Rao N, Santhosh Aruna M, Lakshmi Prasanna J
Chalapathi Institute of Pharmaceutical Sciences,
Lam, Guntur, A.P, India
*Corresponding Author E-mail: manukondakeerthi23@gmail.com
ABSTRACT:
Solid
dispersions are one of the techniques to improve the solubility of the poorly
soluble drugs. In this technique a poorly soluble drug is dispersed in the
highly soluble hydrophilic matrix, two types of polymers are considered as
carriers i.e., lactose, dextrose and cornstarch. Solubility is the basic step
for formulation of different type of dosage forms. clopidogrel bisulphate is a BCS class II drug having
low solubility and high permeability, used as ant platelet drug to inhibit
blood clots in coronary artery disease, peripheral vascular disease and cerebrovascular disease. In this research article Clopidogrel bisulphate solubility has been increased by
co-grinding method i.e.,one
of the solid dispersion technique lactose
(1:5,1:10,1:15), dextrose (1:10,1:15) cornstarch:lactose
(1:10,1:15) from three different polymers cornstarch: lactose showed 99%solubility
than dextrose and lactose. In-vitro
dissolution studies were conducted in PH 6.8 buffer.
KEYWORDS: Clopidogrel
bisulphate, Solid dispersions, Antiplatelet,
Cornstarch: Lactose.
INTRODUCTION:
Biopharmaceutical
classification system (BCS) classified drugs based on the solubility and
permeability. BCS class II drugs having low solubility and high permeability.
The process of drug absorption occurs via dissolution. So it is important for
drugs to increase the bioavailability. Many solubility enhancements techniques
like micronisation, solvent evaporation technique, cogrinding, meltevaporation.
meltcrystallisation, solid
dispersions, microemulsion, hydrotrophy,
precipitation, nanosuspensions are present. Among
those solid dispersions is most widely used method [1] Solid
dispersions mean inserting poorly soluble drug in to inert hydrophilic matrix.
Several water soluble carriers such as methyl cellulose, urea, lactose, citric
acid, polyvinyl pyrrolidone and polyethylene glycols
4000 and 6000 are used as carriers for solid dispersion.
Clopidogrel bisulfate is an anti-platelet drug,
inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel prevents blood
clots by irreversibly binding to the
P2Y12 receptor on platelets, preventing Adenosine Diphosphate
(ADP) from activating platelets. It belongs to a class of drugs called P2Y12
inhibitors.
Clopidogrel
is used for preventing strokes, heart attacks, and death in individuals who
have had a previous stroke, unstable angina, and heart attack or have
peripheral arterial disease (PAD).[2]Drawback with this drug is its
very low solubility (0.0099mg/ml) in biological fluids, which results in poor
bioavailability after oral administration. In the present investigation to
increase the solubility solid dispersion technique is adapted to the drug by
using three hydrophilic carriers. Among them cornstarch: lactose showed best
results compared to lactose and dextrose. In the future studies using these
polymers many formulations can be developed [3].
MATERIALS:
Clopidogrel
bisulphate was obtained as a gift sample from Hetero Drugs, Hyderabad. Lactose,
dextrose, and cornstarch were obtained as a sample from Girijan
Co-operative Corporation Ltd, Srisailam. All other
ingredients are of analytical grade.
METHODS:
Clopidogrel bisulphate solid dispersions were prepared
with three polymers using co-grinding method. Clopidogrel
bisulfate (75mg) triturated with
different ratios of polymers lactose
(1:5, 1:10, 1:15), dextrose (1:10,1:15) cornstarch:
lactose (1:10, 1:15) 20 minutes to ensure uniform mixing in geometrical ratio.
Calibration data of pure dug in water, pH1.2, pH6.8 buffer were given in Table
1 and 2. Composition of the formulation and dissolution data of the pure drug
mixture and dissolution data of the drug with polymers were given in the Table
3 and 4 respectively.
Selection of the carrier[4,5]
·
Be
freely water-soluble with intrinsic rapid dissolution properties.
·
Be
nontoxic and pharmacologically inert
·
Be
heat stable with a low melting point for the melt method.
·
Be
soluble in a variety of solvents and pass through a vitreous state upon solvent
evaporation for the solvent method.
·
Be
able to preferably increase the aqueous solubility of the drug.
Materials used as carriers for solid
dispersions
|
S.NO |
Class |
Examples |
|
1 |
Sugars |
Dextrose, Sucrose,
Galactose, Sorbitol, Maltose,
Mannitol, Lactose |
|
2 |
Acids |
Citricacid,
Succinicacid |
|
3 |
Polymeric
materials |
Povidone,
Polyethylene glycols, Hydroxy propyl
cellulose |
|
4 |
Insoluble
polymers |
Hydroxy propyl methyl cellulose, phthalate, Eudragit
L-100 |
|
5 |
Surfactants |
Polyoxyethylene sterate, Tweens
and Spans |
Standard solution:
75mg of Clopidogrel bisulphate was
dissolved in methanol in a 50ml volumetric flask and the solution was made up
to mark with methanol.
Procedure:
The standard solution of Clopidogrel
bisulphate was subsequently diluted with 0.1N Hcl and
pH6.8 and water to obtain a series of solutions containing 5, 10,
15, 20, 30, 45, 50,60,70 µg of Clopidogrel per ml. The
absorbance of the solutions was measured in ELICO-SL 150UV spectrophotometer at
240nm.
Calibration curve for three buffers showed difference in
solubility pH1.2 > water > pH 6.8. Acidic ph showed more
solubility than basic pH.solid dispersions studied In
vitro dissolution studies in Ph6.8 buffer.
Preparation of solid
dispersions:
The solid dispersions were prepared by co grinding method clopidogrel bisulphate were mixed in various ratios lactose
(1:5, 1:10, 1:15), dextrose (1:10, 1:15) cornstarch: lactose (1:10, 1:15).
Method of preparation of
dispersion by co grinding method[6,7]
The required quantities of drug and carrier as given in table 4
.were triturated in a mortar and pestle thoroughly for 20min.the obtained
powder was sifted through sieve number 80, solid dispersion equivalent to 75mg Clopidogrel was filled in to capsules.
Evaluation of solid
dispersions:
The solid dispersions prepared were evaluated by the dissolution
studies
Dissolution rate studies:
The dissolution rate testing of different Clopidogrel
capsule formulations in table 5 was studied using USPXX1 dissolution rate
testing apparatus (basket type) the basket was rotated at a speed of 50rpm and
the dissolution fluid (900ml 6.8PHmedium) was maintained at a temperature of
37.5˚±0.5˚c.at specific time intervals a 5ml aliquot withdrawn and
replaced to maintain sink condition. The obtained samples were analyzed at 240nm[8-10]
The dissolution profiles of Clopidogrel
bisulphate solid dispersions from various formulations are given in the tables
6 and 7 and graphs 4, 5 and 6.
CONCLUSION:
Solid dispersions of Clopidogrel
bisulphate prepared using cornstarch: lactose by co grinding method showed
better dissolution than the pure drug. Cornstarch: lactose showed more
solubility of drug compared to dextrose and lactose.
ACKNOWLEDGEMENT:
The authors are thankful to Chalapathi
Institute of Pharmaceutical Sciences for providing facilities for bringing out
this work.
Table 1: Calibration of Clopidogrel
bisulphate in water at 240nm
|
S. NO |
Concentration (ug/ml) |
Trail I |
Trail II |
Trail III |
Absorbance |
|
1 |
5 |
0.280 |
0.271 |
0.269 |
0.273 |
|
2 |
10 |
0.382 |
0.369 |
0.389 |
0.380 |
|
3 |
15 |
0.487 |
0.479 |
0.483 |
0.483 |
|
4 |
20 |
0.584 |
0.562 |
0.568 |
0.571 |
|
5 |
25 |
0.678 |
0.658 |
0.668 |
0.668 |
|
6 |
30 |
0.785 |
0.783 |
0.775 |
0.781 |
|
7 |
35 |
0.869 |
0.864 |
0.864 |
0.865 |
|
8 |
40 |
0.890 |
0.899 |
0.890 |
0.895 |
Table 2: Calibration of Clopidogrel
bisulphate in PH1.2 at 240nm
|
S. NO |
Concentration(ug/ml) |
Trail
I |
Trail II |
Trail III |
Absorbance |
|
1 |
10 |
0.215 |
0.248 |
0.218 |
0.227 |
|
2 |
20 |
0.326 |
0.354 |
0.325 |
0.335 |
|
3 |
30 |
0.434 |
0.478 |
0.445 |
0.452 |
|
4 |
40 |
0.545 |
0.578 |
0.567 |
0.563 |
|
5 |
50 |
0.658 |
0.689 |
0.680 |
0.675 |
|
6 |
60 |
0.741 |
0.798 |
0.790 |
0.776 |
|
7 |
70 |
0.849 |
0.890 |
0.891 |
0.876 |
Table 3: Calibration of Clopidogrel
bisulphate in PH6.8 at 240nm
|
S. NO |
Concentration(ug/ml) |
Trail I |
Trail II |
Trail III |
Absorbance |
|
1 |
10 |
0.194 |
0.256 |
0.239 |
0.229 |
|
2 |
20 |
0.304 |
0.345 |
0.340 |
0.331 |
|
3 |
30 |
0.426 |
0.458 |
0.451 |
0.447 |
|
4 |
40 |
0.575 |
0.560 |
0.568 |
0.567 |
|
5 |
50 |
0.686 |
0.654 |
0.689 |
0.676 |
|
6 |
60 |
0.796 |
0.780 |
0.784 |
0.786 |
|
7 |
70 |
0.898 |
0.894 |
0.890 |
0.894 |
Table 4: Amount of Clopidogrel bisulphate and carriers in solid dispersions
|
S. No |
Formulation |
Amt of drug (mg) |
Amount of carrier (mg) |
|
1 |
L1(1:5) |
75 |
375 |
|
2 |
L2(1:10) |
75 |
750 |
|
3 |
L3(1:20) |
75 |
1500 |
|
4 |
D1(1:10) |
75 |
750 |
|
5 |
D2(1:15) |
75 |
1125 |
|
6 |
CS:L1(1:10 |
75 |
750 |
|
7 |
CS:L2(1:15) |
75 |
1125 |
Table 5: List of different Clopidogrel capsule formulations
|
S. No. |
Formulation |
Composition |
|
1 |
A |
Pure drug( CL.G) |
|
2 |
B |
Pure drug in
0.1Hcl |
|
3 |
C |
Pure drug in 6.8
buffer |
|
4 |
L1 |
CL.G:LACTOSE(1:5) |
|
5 |
L2 |
CL.G:LACTOSE(1:10) |
|
6 |
L3 |
CL.G:LACTOSE(1:20) |
|
7 |
D1 |
CL.G:DEXTROSE(1:10) |
|
8 |
D2 |
CL.G:DEXTROSE(1:15) |
|
9 |
CS:L1 |
CL.G:CORNSTARCH:LACTOSE(1:10) |
|
10 |
CS:L2 |
CL.G:CORNSTARCH:LACTOSE(1:15) |
Table 6: Dissolution profiles
of Clopidogrel bisulphate from capsules containing
pure drug in a different mediums
|
S.NO |
Time(mts) |
%Clopidogrel
dissolved |
||
|
Water |
Ph1.2 |
Ph6.8 |
||
|
1 |
5 |
29.493 |
63.122 |
17.4 |
|
2 |
10 |
32.083 |
72.618 |
18.72 |
|
3 |
20 |
36.309 |
84.669 |
21.96 |
|
4 |
30 |
42.316 |
87.076 |
22.8 |
|
5 |
45 |
48.681 |
90.28 |
24.12 |
Figure 1: Calibration curve of
a drug in acidic medium
Figure 2 :
calibration curve of a drug in water
Figure 3 :
calibration curve of a drug in basic medium
Figure 4 :
Comparison of pure drug dissolution in three mediums
Table 7: Dissolution profiles
of Clopidogrel bisulphate from capsules containing
pure drug and different ratios of carriers in ph6.8 buffer
|
S. NO |
Time (mts) |
%Clopidogrel
bisulphate dissolved |
||||||
|
L1 |
L2 |
L3 |
D1 |
D2 |
CS:L1 |
CS:L2 |
||
|
1 |
5 |
42.744 |
53.04 |
69.72 |
58.08 |
59.28 |
52.44 |
58.32 |
|
2 |
10 |
46.272 |
57.12 |
77.04 |
64.68 |
69.12 |
62.88 |
66.24 |
|
3 |
20 |
49.452 |
60.24 |
78.96 |
71.64 |
76.08 |
66.84 |
80.88 |
|
4 |
30 |
54.456 |
63.12 |
84.12 |
77.61 |
83.04 |
83.76 |
93.12 |
|
5 |
45 |
57.852 |
72.6 |
95.52 |
84.12 |
97.68 |
84.24 |
99.09 |
Figure5: Comparison of Three Polymers Solid
Dispersions Highest Concentration
REFERENCES:
1.
Varun Raj Vemula, Venkateshwarlu Lagishetty. Solubility Enhancement Techniques.
International Journal of Pharmaceutical Sciences Review and Research. 2010;
5(1) 41-51.
2.
Redya Naik, Aishwarya Madikanti, T.Sunitha .Formulation
and Evaluation of oral dispersible tablets of Clopidogrel
bisulfate by solid dispersion method. Indo American Journal of Pharmaceutical
Research.2014; 4(7) 3152-3162
3.
Sahitya, B. Krishnamoorthy M. Muthukumaran, G. Kishore.
Formulation and Evaluation of fast dissolving tablets using solid dispersion of
Clopidogrel bisulphate. Int. Journal Adv Pharm Gen Res 2014; 2(1): 15- 23.
4.
Balvinder Dhillon, Narendra,
Goyal, Rishabha Malviya and Pramod K. Sharma.
Poorly Water Soluble Drugs: Change in Solubility for Improved Dissolution
Characteristics a Review. Global Journal of Pharmacology, 2014;8 (1): 26-35.
5.
Varun Raj Vemula, Venkateshwarlu Lagishetty, Srikanth Lingala. Solubility
enhancement techniques. International Journal of Pharmaceutical Sciences Review
and Research. 2010; 5(1), 41-52.
6.
K.
Rama Koteswara Rao, K. Rajya Lakshmi. Design,
development and evaluation of clopidogrel bisulfate
floating tablets. Int J Pharma
Investig 2014;4,19-26.
7.
Kotta Kranthi Kumar, K. Sampath Kumar,
G. Satheesh. Formulation and Evaluation of Clopidogrel bisulfate immediate release tablets. IJPT 2013;
5(2): 5481-5504.
8.
M. Santhosh Aruna, Kishore Babu, Madhurilatha
Thadanki. Solid dispersions an
approach to enhance the dissolution rate of Clopidogrel
bisulphate. International Journal of Research in Pharmacy and Chemistry.2011;1/(4),780-788.
9.
Dhirendra
K. Solid dispersions: a Review, Pak. J. Pharm. Sci
2009; 22(2):234-246.
10.
Mogal S.
A, Gurjar P. N, Yamgar D. S
and Kamod A.C. Solid dispersion technique for
improving solubility of some poorly soluble drugs. Scholars Research Library Der Pharmacia Lettre, 2012, 4
(5):1574-1586
Received on 26.09.2014 Accepted on 30.10.2014
© Asian Pharma
Press All Right Reserved
Asian J. Res.
Pharm. Sci. 4(4): Oct.-Dec.
2014; Page 165-168